药品“零差率”下基层医疗机构补偿机制转变实证分析  

Empirical Analysis of the Subsidy Mechanism in China's Primary Health Institutions Under the Zero Makeup Policy

作　　者：杨廉平[1] 唐玉清[1] 张小鹏[1] 杜鑫[1] 王利军[1] 殷希[1] 杨诗汝[1] 王洪涛[1] 张新平[1] 

机构地区：[1]华中科技大学同济医学院医药卫生管理学院,湖北武汉430030

出　　处：《中国医院管理》2013年第10期45-47,共3页Chinese Hospital Management

基　　金：国家自然科学基金资助项目(71173082)

摘　　要：目的为完善我国基层医疗卫生机构补偿机制提供参考。方法在全国选取山东、湖北、四川三省,采用问卷收集了60家基层医疗卫生机构财务数据,用SPSS完成统计学分析。结果 2011年我国基层医疗卫生机构总收入平均为457.1万元,比历史同期增长12.38%。药品收入为133.54万元,相比2010年下降12.70%,药占比由38.28%降为28.80%;政府投入为170.00万元,增长50.44%,占总收入比例由26.88%上升为36.32%;医疗业务收入增加不明显,但检查收入显著增加。政府投入增长显著,且在各地区水平均衡。结论政府投入增加稳定了机构总收入,保障机构正常运营;要关注医疗机构检查收入的不合理增长;应提高政府投入的有效性,构建科学绩效考核制度,加强定量研究分析。Objective To provide references for the improvement of subsidy mechanism in primary health institutions. Methods 60 primary health care institutions were sampled and investigated in Shandong, Hubei and Sichuan Province. Results In 2011, revenue of primary health institutions raised to 4 571 thousand yuan, with an increase of 12.38% com pared with 2010. Drug revenue was 1 335.4 thousand yuan in 2011, with a drop of 12.70%. Government subsidy was 1 700.0 thousand yuan, with an increase of 50.44%, and government subsidy＇s proportion increased from 26.88% to 36.32%. Medical revenue did not increase significantly, but medical test revenue did. The government input basically balanced in different areas. Conclusion The increase of government inputs maintained the normal operation of institutions, and institutions＇ sources of income became more reasonable. Unreasonable examination revenue should be concerned. Scientific performance appraisal system should be built to improve the cost-effectiveness of government subsidy.

关 键 词：基层医疗卫生机构 补偿机制 政府投入药品收入 

分 类 号：R95[医药卫生—药学]